Beam Therapeutics Inc. (BEAM) has 19 bekannte Insider- und institutionelle Anteilseigner verzeichnet. Der größte Anteilseigner ist Pershing Square Capital Management, L.P. mit 14,818,545 Aktien. Weitere bedeutende Anteilseigner sind Evans John M. und Ciaramella Giuseppe.
In den letzten 12 Monaten haben Insider 44 Transaktionen in BEAM Aktien getätigt — 19 Käufe (im Wert von $17.63M) und 18 Verkäufe (im Wert von $4.17M). Insider-Käufe haben die Verkäufe übertroffen, was auf Vertrauen in die Unternehmensaussichten hindeuten kann.
BEAM Insider-Beteiligungen
Größter Aktionär
Pershing Square Capital Management, L.P.
14,818,545 Aktien
Käufe (12 Monate)
19
$17.63M Wert
Verkäufe (12 Monate)
18
$4.17M Wert
12-Monats-Transaktionsaktivität
Top-Insider-Aktionäre
| # |
Name |
Funktion |
Gehaltene Aktien |
Zuletzt gemeldet |
Relative Größe |
| 1 |
Pershing Square Capital Management, L.p. |
10 Percent Owner |
14,818,545 |
2014-02-03 |
|
| 2 |
Evans John M. |
CEO |
1,047,205 |
2026-04-06 |
|
| 3 |
Ciaramella Giuseppe |
President |
218,406 |
2026-04-06 |
|
| 4 |
Bellon Christine |
Chief Legal Officer |
109,711 |
2026-04-06 |
|
| 5 |
Emany Sravan Kumar |
Chief Financial Officer |
105,456 |
2026-04-02 |
|
| 6 |
Simon Amy |
Chief Medical Officer |
102,735 |
2026-04-06 |
|
| 7 |
Cavanagh Bethany J |
SVP, Finance and Treasurer |
51,171 |
2026-04-06 |
|
| 8 |
Ho Carole |
Director |
33,662 |
2025-06-06 |
|
| 9 |
Fishman Mark |
Director |
33,662 |
2025-06-06 |
|
| 10 |
Cooper Graham K |
Director |
33,662 |
2025-06-06 |
|
| 11 |
Guindo Chirfi |
Director |
33,662 |
2025-06-06 |
|
| 12 |
Shaw Christi |
Director |
33,662 |
2025-06-06 |
|
| 13 |
Maraganore John |
Director |
33,662 |
2025-06-06 |
|
| 14 |
Walsh Kathleen E |
Director |
33,662 |
2025-06-06 |
|
| 15 |
Burrell Terry-ann |
Chief Financial Officer |
25,000 |
2024-04-29 |
|
| 16 |
Burow Kristina |
Director |
16,532 |
2023-06-08 |
|
| 17 |
Nelsen Robert |
10 Percent Owner |
14,053 |
2021-04-02 |
|
| 18 |
Arch Venture Partners Ix, Llc |
10 Percent Owner |
4,867 |
2021-07-02 |
|
| 19 |
Fmr Llc |
10 Percent Owner, Other: See Remark 1 |
14 |
2025-10-29 |
|
Aktuelle Transaktionen (letzte 12 Monate)
| Datum |
Name |
Funktion |
Typ |
Aktien |
Kurs |
Wert |
| 2026-04-01 |
Cavanagh Bethany J |
SVP, Finance and Treasurer |
Informierter Verkauf |
3,242 |
$24.58 |
$79.69K |
| 2026-04-01 |
Simon Amy |
Chief Medical Officer |
Informierter Verkauf |
6,700 |
$24.58 |
$164.69K |
| 2026-04-01 |
Bellon Christine |
Chief Legal Officer |
Informierter Verkauf |
5,956 |
$24.58 |
$146.4K |
| 2026-04-01 |
Ciaramella Giuseppe |
President |
Informierter Verkauf |
11,810 |
$24.58 |
$290.29K |
| 2026-04-01 |
Evans John M. |
CEO |
Informierter Verkauf |
30,078 |
$24.58 |
$739.32K |
| 2026-03-31 |
Cavanagh Bethany J |
SVP, Finance and Treasurer |
RSU-Zuteilung |
20,000 |
- |
- |
| 2026-03-31 |
Simon Amy |
Chief Medical Officer |
RSU-Zuteilung |
31,750 |
- |
- |
| 2026-03-31 |
Bellon Christine |
Chief Legal Officer |
RSU-Zuteilung |
20,000 |
- |
- |
| 2026-03-31 |
Emany Sravan Kumar |
Chief Financial Officer |
RSU-Zuteilung |
31,750 |
- |
- |
| 2026-03-31 |
Ciaramella Giuseppe |
President |
RSU-Zuteilung |
40,000 |
- |
- |
| 2026-03-31 |
Evans John M. |
CEO |
Optionsausübung (Verkauf) |
25,000 |
$0.67 |
$16.75K |
| 2026-03-30 |
Evans John M. |
CEO |
Optionsausübung (Verkauf) |
25,000 |
$0.67 |
$16.75K |
| 2026-02-24 |
Ciaramella Giuseppe |
President |
Informierter Verkauf |
35,000 |
$32.00 |
$1.12M |
| 2026-01-31 |
Cavanagh Bethany J |
SVP, Finance and Treasurer |
RSU-Zuteilung |
40,000 |
$27.62 |
$1.1M |
| 2026-01-31 |
Simon Amy |
Chief Medical Officer |
RSU-Zuteilung |
88,500 |
$27.62 |
$2.44M |
| 2026-01-31 |
Bellon Christine |
Chief Legal Officer |
RSU-Zuteilung |
40,000 |
$27.62 |
$1.1M |
| 2026-01-31 |
Emany Sravan Kumar |
Chief Financial Officer |
RSU-Zuteilung |
63,500 |
$27.62 |
$1.75M |
| 2026-01-31 |
Ciaramella Giuseppe |
President |
RSU-Zuteilung |
80,000 |
$27.62 |
$2.21M |
| 2026-01-31 |
Evans John M. |
CEO |
RSU-Zuteilung |
180,000 |
$27.62 |
$4.97M |
| 2026-01-30 |
Evans John M. |
CEO |
Optionsausübung (Verkauf) |
25,000 |
$0.67 |
$16.75K |
| 2026-01-29 |
Evans John M. |
CEO |
Optionsausübung (Verkauf) |
19,336 |
$0.67 |
$12.96K |
| 2026-01-22 |
Cavanagh Bethany J |
SVP, Finance and Treasurer |
Informierter Verkauf |
6,198 |
$35.00 |
$216.93K |
| 2026-01-22 |
Bellon Christine |
Chief Legal Officer |
Informierter Verkauf |
1,371 |
$34.00 |
$46.61K |
| 2026-01-20 |
Cavanagh Bethany J |
SVP, Finance and Treasurer |
Informierter Verkauf |
3,034 |
$30.12 |
$91.38K |
| 2026-01-15 |
Bellon Christine |
Chief Legal Officer |
Informierter Verkauf |
559 |
$35.40 |
$19.79K |
